These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33802253)

  • 21. Impact of electrical cardioversion on quality of life for patients with symptomatic persistent atrial fibrillation: Is there a treatment expectation effect?
    Ha ACT; Stewart J; Klein G; Roy D; Connolly S; Koren A; Dorian P
    Am Heart J; 2020 Aug; 226():152-160. PubMed ID: 32580074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rate control versus electrical cardioversion for atrial fibrillation: A randomised comparison of two treatment strategies concerning morbidity, mortality, quality of life and cost-benefit - the RACE study design.
    van Gelder IC; Hagens VE; Kingma JH; Bosker HA; Kamp O; Kingma T; Veeger NJ; Bouma J; TenVergert EM; Tijssen JG; Crijns HJ
    Neth Heart J; 2002 Mar; 10(3):118-124. PubMed ID: 25696077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term and long-term success of electrical cardioversion in atrial fibrillation in managed care system.
    Kuppahally SS; Foster E; Shoor S; Steimle AE
    Int Arch Med; 2009 Dec; 2():39. PubMed ID: 20003371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serial antiarrhythmic therapy: role of amiodarone in prevention of atrial fibrillation recurrence--a lesson from the HOT CAFE Polish Study.
    Kosior DA; Opolski G; Wozakowska-Kaplon B; Rabczenko D;
    Cardiology; 2005; 104(1):35-44. PubMed ID: 15942183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epicardial fat thickness: A new predictor of successful electrical cardioversion and atrial fibrillation recurrence.
    Dereli S; Bayramoğlu A; Yontar OC; Cerşit S; Gürsoy MO
    Echocardiography; 2018 Dec; 35(12):1926-1931. PubMed ID: 30387182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation.
    Frick M; Frykman V; Jensen-Urstad M; Ostergren J; Rosenqvist M
    Clin Cardiol; 2001 Mar; 24(3):238-44. PubMed ID: 11288971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amiodarone after unsuccessful direct-current cardioversion of persistent atrial fibrillation.
    Kosior DA; Wozakowska-Kapłon B; Jasik M; Kiliszek M; Rabczenko D; Opolski G
    Kardiol Pol; 2005 Dec; 63(6):585-92; discussion 593-4. PubMed ID: 16380855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mechanical fibrillation pattern of the atrial myocardium is associated with acute and long-term success of electrical cardioversion in patients with persistent atrial fibrillation.
    De Vos CB; Limantoro I; Pisters R; Delhaas T; Schotten U; Cheriex EC; Tieleman RG; Crijns HJ
    Heart Rhythm; 2014 Sep; 11(9):1514-21. PubMed ID: 24768608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.
    Capucci A; Villani GQ; Aschieri D; Rosi A; Piepoli MF
    Eur Heart J; 2000 Jan; 21(1):66-73. PubMed ID: 10610746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre- and post-treatment with amiodarone for elective electrical cardioversion of atrial fibrillation: a systematic review and meta-analysis.
    Um KJ; McIntyre WF; Healey JS; Mendoza PA; Koziarz A; Amit G; Chu VA; Whitlock RP; Belley-Côté EP
    Europace; 2019 Jun; 21(6):856-863. PubMed ID: 30875422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reverse atrial remodeling in patients who maintain sinus rhythm after electrical cardioversion: evidence derived from the measurement of total atrial conduction time assessed by PA-TDI interval.
    Müller P; Schiedat F; Dietrich JW; Shin DI; Kara K; Mügge A; Deneke T
    J Echocardiogr; 2014 Dec; 12(4):142-50. PubMed ID: 27277168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overtreatment and undertreatment with anticoagulation in relation to cardioversion of atrial fibrillation (the RHYTHM-AF study).
    Lip GY; Gitt AK; Le Heuzey JY; Bash LD; Morabito CJ; Bernhardt AA; Sisk CM; Chazelle F; Crijns HJ;
    Am J Cardiol; 2014 Feb; 113(3):480-4. PubMed ID: 24332698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High serum potassium level is associated with successful electrical cardioversion for new-onset atrial fibrillation in the intensive care unit: A retrospective observational study.
    Kyo M; Hosokawa K; Ohshimo S; Kida Y; Tanabe Y; Ota K; Shime N
    Anaesth Intensive Care; 2019 Jan; 47(1):52-59. PubMed ID: 30864476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological cardioversion of atrial fibrillation: current management and treatment options.
    Boriani G; Diemberger I; Biffi M; Martignani C; Branzi A
    Drugs; 2004; 64(24):2741-62. PubMed ID: 15563247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of platelet to lymphocyte ratio for predicting recurrence of atrial fibrillation after direct current cardioversion.
    Dereli S; Bayramoğlu A; Yontar OC
    Ann Noninvasive Electrocardiol; 2019 Mar; 24(2):e12616. PubMed ID: 30414335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Sacubitril-Valsartan on Restoration and Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation.
    Chen Q; Chen Y; Qin F; Du H; Gan C; Zhou B; Wang N; Xiao M; Ou Z; Zhao W; Cui B; Liu Z; Yin Y
    Front Cardiovasc Med; 2022; 9():870203. PubMed ID: 35707128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of sinus rhythm maintenance on left heart function after electrical cardioversion of atrial fibrillation: implications for tachycardia-induced cardiomyopathy.
    Zimmermann AJ; Bossard M; Aeschbacher S; Schoen T; Voellmin G; Suter Y; Lehmann A; Hochgruber T; Pumpol K; Sticherling C; Kühne M; Conen D; Kaufmann BA
    Can J Cardiol; 2015 Jan; 31(1):36-43. PubMed ID: 25547548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of bepridil in combination with Ic antiarrhythmic agent in converting persistent atrial fibrillation to sinus rhythm.
    Imai S; Saito F; Takase H; Enomoto M; Aoyama H; Yamaji S; Yokoyama K; Yagi H; Kushiro T; Hirayama A
    Circ J; 2008 May; 72(5):709-15. PubMed ID: 18441448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VERDICT: the Verapamil versus Digoxin Cardioversion Trial: A randomized study on the role of calcium lowering for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation.
    Van Noord T; Van Gelder IC; Tieleman RG; Bosker HA; Tuinenburg AE; Volkers C; Veeger NJ; Crijns HJ
    J Cardiovasc Electrophysiol; 2001 Jul; 12(7):766-9. PubMed ID: 11469424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.
    Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Piccione G; Di Giovanni N; Colletti A; Pensabene O; Lisi F; Vasquez L; Grammatico A; Boriani G;
    Am Heart J; 2008 Jan; 155(1):100-7, 107.e1. PubMed ID: 18082498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.